Participants in pragmatic clinical trials often partially adhere to treatment. In the presence of partial adherence, simple statistical analyses of binary adherence (receiving either full or no treatment) introduce biases. We developed a framework which expands the principal strati cation approach to allow partial adherers to have their own principal stratum and treatment level. We derived consistent estimates for bounds on population values of interest. A Monte Carlo posterior sampling method was derived that is computationally faster than Markov Chain Monte Carlo sampling, with con firmed equivalent results. Simulations indicate that the two methods agree with each other and are superior in most cases to the biased estimators created thro...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Background Two-stage least square [2SLS] and two-stage residual inclusion [2SRI] ar...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Participants in pragmatic clinical trials often partially adhere to treatment. In the presence of pa...
Much research in the social and health sciences aims to understand the causal relationship between a...
Introduction: The instrumental variable (IV)-based methods (e.g., two-stage least square [2SLS], two...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
The Principal Stratification method estimates a causal intervention effect by taking account of subj...
We consider studies for evaluating the short-term effect of a treatment of interest on a time-to-eve...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
A recent solution to estimating treatment efficacy in studies with non-compliance has been the devel...
In assessing the mechanism of treatment efficacy in randomized clinical trials, investigators often ...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Background Two-stage least square [2SLS] and two-stage residual inclusion [2SRI] ar...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Participants in pragmatic clinical trials often partially adhere to treatment. In the presence of pa...
Much research in the social and health sciences aims to understand the causal relationship between a...
Introduction: The instrumental variable (IV)-based methods (e.g., two-stage least square [2SLS], two...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
In pragmatic trials, treatment strategies are randomly assigned at baseline, but patients may not ad...
The Principal Stratification method estimates a causal intervention effect by taking account of subj...
We consider studies for evaluating the short-term effect of a treatment of interest on a time-to-eve...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
A recent solution to estimating treatment efficacy in studies with non-compliance has been the devel...
In assessing the mechanism of treatment efficacy in randomized clinical trials, investigators often ...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...
Background Two-stage least square [2SLS] and two-stage residual inclusion [2SRI] ar...
Protocol non-adherence is common and poses unique challenges in the interpretation of trial outcomes...